Felix Kartnig
Vienna, Austria
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 24 publications
Antibody development after three mRNA SARS-CoV-2 vaccinations in patients with systemic autoimmune rheumatic disease with and without treatment: an observational cohort study.
Journal: BMJ open
Published: September 23, 2025
Image-based drug screening combined with molecular profiling identifies signatures and drivers of therapy resistance in pediatric AML.
Journal: Cell reports. Medicine
Published: November 28, 2024
Humoral and cellular response to the third COVID-19 vaccination in patients with inborn errors of immunity or mannose-binding lectin deficiency : A prospective controlled open-label trial.
Journal: Wiener klinische Wochenschrift
Published: July 07, 2024
Ex vivo imaging-based high content phenotyping of patients with rheumatoid arthritis.
Journal: EBioMedicine
Published: May 23, 2024
A conformation-locking inhibitor of SLC15A4 with TASL proteostatic anti-inflammatory activity.
Journal: Nature communications
Published: March 24, 2023
Amino Acids Fueling Fibroblast-Like Synoviocyte Activation and Arthritis By Regulating Chemokine Expression and Leukocyte Migration.
Journal: Arthritis & rheumatology (Hoboken, N.J.)
Published: December 20, 2022
Accelerated waning of immune responses to a third COVID-19 vaccination in patients with immune-mediated inflammatory diseases.
Journal: Journal of autoimmunity
Published: November 24, 2022
Cytokine-directed cellular cross-talk imprints synovial pathotypes in rheumatoid arthritis.
Journal: Annals of the rheumatic diseases
Published: September 23, 2022
The accelerated waning of immunity and reduced effect of booster in patients treated with bDMARD and tsDMARD after SARS-CoV-2 mRNA vaccination.
Journal: Frontiers in medicine
Published: September 20, 2022
Reactogenicity and immunogenicity of the second COVID-19 vaccination in patients with inborn errors of immunity or mannan-binding lectin deficiency.
Journal: Frontiers in immunology
Published: June 21, 2022
Safety and immunogenicity of a third COVID-19 vaccination in patients with immune-mediated inflammatory diseases compared with healthy controls.
Journal: Annals of the rheumatic diseases
Published: April 20, 2022
Immunogenicity and safety of a fourth COVID-19 vaccination in rituximab-treated patients: an open-label extension study.
Journal: Annals of the rheumatic diseases
Published: March 31, 2022
Last Updated: 09/26/2026